Skip to main content
KALV logo
KALV
(NASDAQ)
KalVista Pharmaceuticals, Inc.
$26.81-- (--)
Loading... - Market loading

KalVista Pharmaceuticals (KALV) Stock Price & Financial Analysis

KalVista Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.72 - $26.77
52-Week High$26.85
52-Week Low$9.83
Open$26.77
Volume2.05M
Average Volume (3M)4.92M
Market Cap1.35B
Shares Outstanding50.54M
Price to Sales (P/S)15.22
Price to Book (P/B)-498.28
EV/EBITDA-8.05
Revenue (TTM)88.73M
Net Income (TTM)-164.43M
Free Cash Flow (TTM)-96.92M
EPS (TTM)$-3.11
Profit Margin-185.31%
Operating Margin-185.29%
50-Day MA$20.11
200-Day MA$15.46
52-Week Change119.29%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About KalVista Pharmaceuticals

What is the current stock price for KALV?

As of the latest trading session, KALV stock trades at $26.76. The 52-week range is $9.83–$26.85, with a day range of $26.72–$26.77.

What is the P/E ratio for KALV?

The P/E ratio (Price-to-Earnings) for KALV is shown in the Key Statistics section. This valuation metric helps compare KalVista Pharmaceuticals, Inc. to industry peers.

Does KALV pay dividends?

KalVista Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KALV?

Based on 3 analysts, the consensus for KALV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KALV?

KalVista Pharmaceuticals's market capitalization is $1.35B, classifying it as a small-cap company..